Your browser doesn't support javascript.
loading
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
Divoux, Jordane; Florent, Romane; Jacobs, Margaux; Lequesne, Justine; Grellard, Jean-Michel; San, Chankannira; Grossi, Sara; Kerdja, Katia; Clarisse, Bénédicte; Boudier, Gwenaelle; Cherifi, François; Briand, Mélanie; Dolivet, Enora; Johnson, Alisson; Dubois, Brice; Harter, Valentin; Lacroix, Joëlle; Raboutet, Charlotte; Marie, Brigitte; Rousseau, Nathalie; Blanc-Fournier, Cécile; Vaur, Dominique; Figeac, Martin; Poulain, Laurent; Weiswald, Louis-Bastien; Emile, George.
Afiliação
  • Divoux J; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.
  • Florent R; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.
  • Jacobs M; US PLATON, ORGAPRED Core Facility, Université de Caen Normandie, Caen, France.
  • Lequesne J; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.
  • Grellard JM; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France.
  • San C; US PLATON, ORGAPRED Core Facility, Université de Caen Normandie, Caen, France.
  • Grossi S; Comprehensive Cancer Center François Baclesse, Breast Cancer Unit, UNICANCER, Institut Normand du Sein, Caen, France.
  • Kerdja K; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Clarisse B; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Boudier G; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Cherifi F; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Briand M; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Dolivet E; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Johnson A; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Dubois B; Comprehensive Cancer Center François Baclesse, Breast Cancer Unit, UNICANCER, Institut Normand du Sein, Caen, France.
  • Harter V; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.
  • Lacroix J; US PLATON, Biological Resource Center 'OvaRessources', Université de Caen Normandie, Caen, France.
  • Raboutet C; INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), Université de Caen Normandie, Caen, France.
  • Marie B; Comprehensive Cancer Center François Baclesse, Department of Surgery, UNICANCER, Caen, France.
  • Rousseau N; Comprehensive Cancer Center François Baclesse, Breast Cancer Unit, UNICANCER, Institut Normand du Sein, Caen, France.
  • Blanc-Fournier C; Comprehensive Cancer Center François Baclesse, Clinical Research Department, UNICANCER, Caen, France.
  • Vaur D; Comprehensive Cancer Center François Baclesse, North-West Canceropole Data Center, UNICANCER, Caen, France.
  • Figeac M; Comprehensive Cancer Center François Baclesse, North-West Canceropole Data Center, UNICANCER, Caen, France.
  • Poulain L; Comprehensive Cancer Center François Baclesse, Department of Radiology, UNICANCER, Caen, France.
  • Weiswald LB; Comprehensive Cancer Center François Baclesse, Department of Radiology, UNICANCER, Caen, France.
  • Emile G; Comprehensive Cancer Center François Baclesse, Department of Radiology, UNICANCER, Caen, France.
BMC Cancer ; 23(1): 883, 2023 Sep 19.
Article em En | MEDLINE | ID: mdl-37726786
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França